Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 1
1998 1
2000 1
2001 1
2003 1
2005 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

7 results
Results by year
Filters applied: . Clear all
Page 1
Bayesian hierarchical models.
Schmid CH, Brown EN. Schmid CH, et al. Methods Enzymol. 2000;321:305-30. doi: 10.1016/s0076-6879(00)21200-7. Methods Enzymol. 2000. PMID: 10909064 Review. No abstract available.
An empirical study of the effect of the control rate as a predictor of treatment efficacy in meta-analysis of clinical trials.
Schmid CH, Lau J, McIntosh MW, Cappelleri JC. Schmid CH, et al. Stat Med. 1998 Sep 15;17(17):1923-42. doi: 10.1002/(sici)1097-0258(19980915)17:17<1923::aid-sim874>;2-6. Stat Med. 1998. PMID: 9777687 Review.
Large trials vs meta-analysis of smaller trials: how do their results compare?
Cappelleri JC, Ioannidis JP, Schmid CH, de Ferranti SD, Aubert M, Chalmers TC, Lau J. Cappelleri JC, et al. JAMA. 1996 Oct 23-30;276(16):1332-8. JAMA. 1996. PMID: 8861993 Review.
The rate of progression of renal disease may not be slower in women compared with men: a patient-level meta-analysis.
Jafar TH, Schmid CH, Stark PC, Toto R, Remuzzi G, Ruggenenti P, Marcantoni C, Becker G, Shahinfar S, De Jong PE, De Zeeuw D, Kamper AL, Strangaard S, Levey AS. Jafar TH, et al. Nephrol Dial Transplant. 2003 Oct;18(10):2047-53. doi: 10.1093/ndt/gfg317. Nephrol Dial Transplant. 2003. PMID: 13679479
The effect of angiotensin-converting-enzyme inhibitors on progression of advanced polycystic kidney disease.
Jafar TH, Stark PC, Schmid CH, Strandgaard S, Kamper AL, Maschio G, Becker G, Perrone RD, Levey AS; ACE Inhibition in Progressive Renal Disease (AIPRD) Study Group. Jafar TH, et al. Kidney Int. 2005 Jan;67(1):265-71. doi: 10.1111/j.1523-1755.2005.00077.x. Kidney Int. 2005. PMID: 15610250 Free article.
Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease.
Jafar TH, Stark PC, Schmid CH, Landa M, Maschio G, Marcantoni C, de Jong PE, de Zeeuw D, Shahinfar S, Ruggenenti P, Remuzzi G, Levey AS; AIPRD Study Group. Angiotensin-Converting Enzymne Inhibition and Progression of Renal Disease. Jafar TH, et al. Kidney Int. 2001 Sep;60(3):1131-40. doi: 10.1046/j.1523-1755.2001.0600031131.x. Kidney Int. 2001. PMID: 11532109 Free article. Clinical Trial.
Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: a meta-analysis of randomized trials. Angiotensin-Converting-Enzyme Inhibition and Progressive Renal Disease Study Group.
Giatras I, Lau J, Levey AS. Giatras I, et al. Ann Intern Med. 1997 Sep 1;127(5):337-45. doi: 10.7326/0003-4819-127-5-199709010-00001. Ann Intern Med. 1997. PMID: 9273824